WebMar 15, 2011 · Amendment to Stock Option This Amendment to Stock Option (this “ Amendment ”) is entered into between Five Prime Therapeutics, Inc., a Delaware corporation (the “ Company ”), and Aron Knickerbocker, effective as of March 15, 2011 (the “ Amendment Effective Date ”). WebEX-10.31 11 d536956dex1031.htm EX-10.31 EX-10.31 . Exhibit 10.31 . FIVE PRIME THERAPEUTICS, INC. 2013 EMPLOYEE STOCK PURCHASE PLAN . The Board of Directors of the Company has adopted this 2013 Employee Stock Purchase Plan to enable eligible employees of the Company and its Participating Affiliates, through payroll …

FIVE PRIME THERAPEUTICS, INC. : All Information and News

WebFIVE PRIME THERAPEUTICS, INC. 2010 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: OCTOBER 28, 2010 APPROVED BY THE STOCKHOLDERS: DECEMBER 9, 2010 TERMINATION DATE: OCTOBER 27, 2024 1. GENERAL. (a) Successor to and Continuation of Prior Plan. WebFive Prime Therapeutics, Inc., a Delaware corporation (the “Company”), hereby grants an option to purchase shares of its common stock, par value $0.001 per share (the “Option”), to the optionee named below, subject to the vesting and other conditions set forth below. how to take anchors out of wall

Five Prime Therapeutics - Funding, Financials, Valuation

WebNov 13, 2024 · SOUTH SAN FRANCISCO, Calif. -- (BUSINESS WIRE)-- Five Prime Therapeutics, Inc. (Nasdaq: FPRX), announced today the pricing of an underwritten public offering of 7,200,000 shares of its... WebFive Prime Therapeutics, Inc., a Delaware corporation (the “ Company ”), proposes to issue and sell to the several underwriters named in Schedule A (the “ Underwriters ”) an aggregate of [ ] shares of its common stock, par value $0.001 per share (the “ Shares ”). The [ ] Shares to be sold by the Company are called the “ Firm Shares .” WebCompany profile page for Five Prime Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information how to take anjeer